跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Approved
STANDARD
VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Astellas Pharma S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 27, 2023
Approval ID
72e6123b2a61e3a0
Company
Astellas Pharma S.R.O.
Type
Standard
Approval Details
Approval Id
72e6123b2a61e3a0
Drug Cima Aemps Name
VOLUTSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Register Number
7343913C
Holder Company Name
Astellas Pharma S.R.O.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-11-27
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
6 mg/0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astellas Pharma S.R.O.
Active Ingredients
TAMSULOSINA HIDROCLORURO
0,4 mg
SOLIFENACINA SUCCINATO
6,0 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 27, 2023
Approval ID
72e6123b2a61e3a0
Type
Standard
Back to CIMA-AEMPS Approvals